TMPRSS2 and prostate carcinoma: Elevated expression of TMPRSS2 in the context of SARS-CoV-2 infections (15) implies that SARS-CoV-2 infection could increase chances of TMPRSS2 fusions, a phenomenon well-associated with prostate cancer development and progression (13).